The Natural History of Geographic Atrophy Progression (GAP) Study
Sponsor
Alcon Research (Industry)
Overall Status
Terminated
CT.gov ID
NCT00599846
Collaborator
(none)
1,000
1
Study Details
Study Description
Brief Summary
The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1000 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Study Start Date
:
Dec 1, 2007
Actual Primary Completion Date
:
Dec 1, 2009
Outcome Measures
Primary Outcome Measures
- GA progression rate using fundus autofluorescence [From baseline]
Secondary Outcome Measures
- GA progression rate using fundus photography [From baseline]
Eligibility Criteria
Criteria
Ages Eligible for Study:
55 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Clinical diagnosis of geographic atrophy secondary to age-related macular degeneration with no CNV lesion.
Exclusion Criteria:
- Age related
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Houston | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- Alcon Research
Investigators
- Study Director: Patricia Zilliox, Alcon Research
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00599846
Other Study ID Numbers:
- C-06-30
First Posted:
Jan 24, 2008
Last Update Posted:
Mar 2, 2010
Last Verified:
Feb 1, 2010
Keywords provided by ,
,
Additional relevant MeSH terms: